Wednesday, November 17, 2021

TTABlog Test: How Did These Recent Section 2(d) Appeals Turn Out?

The TTAB (Tee-Tee-Ā-Bee) recently decided the appeals from the three Section 2(d) refusals described below. No hints today. How do you think they turned out?  [Answer in first comment].

In re Institute of Management Accountants, Serial No. 88626624 (November 9, 2021) [not precedential] (Opinion by Judge Linda A. Kuczma) [Section 2(d) refusal of IMA EXCEL 365: TIPS IN TEN for "a series of online courses demonstrating new excel features helpful to management accountants and financial professionals," in view of the registered mark EXCEL for computer spreadsheet software.]

Argo AI, LLC, Serial No. 88814288 (October 10, 2021) [not precedential] (Opinion by Judge Christopher Larkin) [Section 2(d) refusal of GROUND TRUTH for "On-line journals, namely, blogs featuring autonomous vehicle technology" in view of the registered mark GROUNDTRUTH for various services, including "On-line journals, namely, blogs featuring information written by and for members of local communities around the globe."]

In re BFY LLC, Serial No. 88190652 (November 12, 2021) (Opinion by Judge George C. Pologeorgis)[not precedential] [Section 2(d) refusal of SLEEPEEZ for "Homeopathic pharmaceuticals for use in the treatment of children's sleeping problems; Medicated candies for use in the treatment of children's sleeping problems," in view of the registered mark SLEEPEASE for "Homeopathic preparations in the nature of an oral spray for the treatment of insomnia and symptoms of insomnia such as wakefulness, restlessness, caffeine sensitivity, emotional stress and anxiety."

Read comments and post your comment here.

TTABlog comment: How did you do? See any WYHAs?

Text Copyright John L. Welch 2021.


At 8:06 AM, Blogger John L. Welch said...

All three were affirmed. Surprised?

At 8:41 AM, Anonymous Michael A. Marrero said...

Not surprised.

At 11:41 AM, Anonymous Anonymous said...


At 1:37 PM, Blogger Valerie N said...

No surprises here...


Post a Comment

<< Home